Zura Bio Limited’s filing revealed that its Director Munshi Amit acquired Company’s shares for reported $0.5 million on Jun 05. In the deal valued at $4.25 per share,117,647 shares were bought. As a result of this transaction, Munshi Amit now holds 617,640 shares worth roughly $ 4.31 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Oppenheimer initiated its Zura Bio Limited [ZURA] rating to an Outperform in a research note published on Friday, August 25, 2023; the price target was $17. PT values the company’s stock at a premium of 58.94 to its Friday closing price.
Price Performance Review of ZURA
On Friday, Zura Bio Limited [NASDAQ:ZURA] saw its stock jump 1.45% to $6.98. On the same session, the stock had its day’s lowest price of $6.73, but rose to a high of $7.20. Over the last five days, the stock has gained 1.45%. Zura Bio Limited shares have fallen nearly -31.64% since the year began. Nevertheless, the stocks have fallen -29.21% over the past one year. While a 52-week high of $37.55 was reached on 03/24/23, a 52-week low of $4.87 was recorded on 05/03/23. SMA at 50 days reached $7.03, while 200 days put it at $9.19. A total of 81964.0 shares were traded, compared to the trading of 80000.0 shares in the previous session.
Levels Of Support And Resistance For ZURA Stock
The 24-hour chart illustrates a support level at 6.74, which if violated will result in even more drops to 6.50. On the upside, there is a resistance level at 7.21. A further resistance level may holdings at 7.44. The Relative Strength Index (RSI) on the 14-day chart is 53.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.43%. Stochastics %K at 68.67% indicates the stock is a holding.
How much short interest is there in Zura Bio Limited?
A steep rise in short interest was recorded in Zura Bio Limited stocks on Aug 14, 2023, growing by 7660.0 shares to a total of 0.17 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 0.16 million shares. There was a rise of 4.49%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 0.72% of the overall stock float, the days-to-cover ratio (short ratio) rose to 1.32.
Zura Bio Limited [ZURA] – Who Are The Largest Shareholders?
In filings from Athanor Capital LP, it is revealed that the company now owns 6,801,633 shares, or roughly 15.60% of the outstanding ZURA shares. In other words, the investor’s shares have risen by 309,131 from its previous 13-F filing of 6492502.0.. At present, Citadel Advisors LLC is holding 712,500 shares valued at $4.9 million. Point72 Asset Management LP owned 470,364 shares of the company at the time of its most recent 13F filing, worth $3.24 million.
According to FactSet, Zura Bio Limited’s share price will average $18.25 in the next year, based on opinions of analysts polled by the firm. This is up nearly 168.9 percent from its previous closing price of $6.88. Analysts expect Zura Bio Limited stock to reach the higher price of $22.00, while the lowest price estimate is $14.00. However, 4 analysts have rated ZURA stock as a Buy in their predictions for 2023.